Sandvik mobile crushers & screens deal in Germany Should ramp up to ~15% of German sales, says comp...
Redeye raises its estimates for Energy Save following the strong Q1 2022/23 report and continued sol...
Spherio Group AB (publ) meddelade under torsdagen den 15 september att bolaget har ingått ett avtal ...
Gasprox announced yesterday that it plans to issue a convertible note worth SEK 5.
A deep dive into Alcadon on 29 September Old financial targets to be updated 34% ’21-’24e EBITA CA...
Minskad försäljning inom Health & Wellness Den rapporterade nettoomsättningen för det andra kvartale...
NEX-22: Liraglutide for type 2 diabetes (T2D) Liraglutide (Novo’s Victoza) DKK 15bn in 2021 Precli...
Redeye sees an opportunity for investors to deepen their understanding of Efecte during its Digitali...
We hosted a presentation with CFO Marklund yesterday Some questions answered, others remain More t...
Interest rate sensitivity provided by Trianon Yield of 3.
Kostnaderna tickade nedåt Bolaget visar på bra kontroll av kostnaderna i Q2 och det finansiella läge...
Stabila finanser Bolaget hade ingen nettoomsättning under Q2'22.
Absolicon kan dra nytta av en turbulent energimarknad och intresset för bolagets produkter är stort.
Analysguiden inleder bevakning av ett bolag som lockar med starka varumärken och god lönsamhet.
Contract worth SEK 43m (~11% of FY’23 ABGSCe rev) Expected to be margin accretive on group level ...
We hosted a presentation with CEO Patrik Settlin today B2B and indexed contracts mitigate inflation...
Q2 var en händelserik period för Amniotics, bland annat tillträder en ny VD, finansiering har säkrat...
IRLAB Therapeutics announced that it has completed patient recruitment for its ongoing Phase IIb stu...
Ultimovacs has announced encouraging new data from its completed Phase I study (NCT02275416).
